Trials / Completed
CompletedNCT02995473
Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis
Multi-center, Randomized, Vehicle-controlled, Investigator-blinded, Parallel Groups Study to Evaluate the Efficacy and Safety of NP000888 in Subjects With Plaque and Nail Psoriasis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the efficacy and safety of topical application of NP000888 ointment compared to vehicle in plaque and fingernail psoriasis subjects. Duration of administration: 24 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NP000888 | 270 µg/g topical (BID) for 24 weeks |
| DRUG | Vehicle | Topical (BID) for 24 weeks |
Timeline
- Start date
- 2017-02-08
- Primary completion
- 2018-05-03
- Completion
- 2018-05-28
- First posted
- 2016-12-16
- Last updated
- 2018-06-12
Locations
10 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02995473. Inclusion in this directory is not an endorsement.